Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Sodium channelopathies of skeletal muscle result from gain or loss of function Jurkat-Rott K; Holzherr B; Fauler M; Lehmann-Horn FPflugers Arch 2010[Jul]; 460 (2): 239-48Five hereditary sodium channelopathies of skeletal muscle have been identified. Prominent symptoms are either myotonia or weakness caused by an increase or decrease of muscle fiber excitability. The voltage-gated sodium channel NaV1.4, initiator of the muscle action potential, is mutated in all five disorders. Pathogenetically, both loss and gain of function mutations have been described, the latter being the more frequent mechanism and involving not just the ion-conducting pore, but aberrant pores as well. The type of channel malfunction is decisive for therapy which consists either of exerting a direct effect on the sodium channel, i.e., by blocking the pore, or of restoring skeletal muscle membrane potential to reduce the fraction of inactivated channels.|Action Potentials/physiology[MESH]|Channelopathies/*genetics[MESH]|Humans[MESH]|Hypokalemic Periodic Paralysis/physiopathology[MESH]|Membrane Potentials/physiology[MESH]|Muscle Proteins/chemistry/genetics[MESH]|Muscle, Skeletal/metabolism[MESH]|Myotonic Disorders/drug therapy/*genetics/physiopathology[MESH]|NAV1.4 Voltage-Gated Sodium Channel[MESH]|Paralysis, Hyperkalemic Periodic/physiopathology[MESH]|Potassium/adverse effects[MESH]|Sodium Channels/chemistry/*genetics/physiology[MESH] |
